Although it is a well-known fact that drug resistance towards sulfonamides is easily obtained after a comparatively small number of exposures of the sensitive microorganisms to these drugs in vitro or in vivo,'
by dissolving the tablets or powder in alkali, filtering and adjusting to pH 7.0 to 7.5.
The technique described below was used in rendering E. coli resistant to the sulfonamides in zvtro. The organism was grown in test tubes containing synthetic medium' with decreasing concentrations of the sulfonamides or sulfonamide mixtures made up by the serial dilution method. The range of concentrations was from 0.00049 mg./ml. to 1.0 mg./ml. except in the case of sulfacetamide where the highest concentration used was 5.0 mg./ml. After twenty-four hours' incubation, the first tube showing good growth was used for the inoculation of a new experiment and so on until resistance to 1.0 mg./ml. or 5.0 mg./ml. (sulfacetamide) was achieved.
The inoculum consisted of 0.05 ml. of a 10 dilution of the culture of E. coli (strain J).
The experiments were extended to a period of approximately four weeks or to the time at which full growth was obtained in the highest concentration. 
Experimental
In preliminary experiments it was determined how many passages through drug-containing medium were required to render a strain resistant to 1.0 mg./ml. of the single sulfonamides. The results of these experiments are given in Table 1 .
The data in Table 1 which represent selected steps in the development of drug resistance show that sulfadiazine, sulfathiazole, and Gantrisin rendered the strain of E. coli J resistant to 1.0 mg./ml. after twenty-six passages. The progression of the loss of sensitivity was in all instances almost identical. Comparatively fast development of drug resistance was, however, observed in two instances. The initially highly active sulfamerazine rendered the strain resistant towards the 1.0 mg./ml. concentrations in only twelve passages. Sulfacetamide appeared not only considerably less active than the other four sulfonamides, but resistance developed so fast that the strain was no longer influenced by a concentration of 0.625 mg./ml. after three passages and was completely resistant to 5.0 mg./ml. after seven passages.
The observations in this table were accurately reproducible. Identical experiments to those given in Table 1 were, for instance, carried out at different times with Gantrisin and sulfacetamide. In an experiment with Gantrisin and E. coli J carried out in May-June, 1946, the initial active concentration was 0.00049 mg./ml. After twelve passages the active concentration was 0.025 mg./ml., after eighteen passages 0.25 mg./ml., and after twenty-six passages the resistant organism grew in a concentration of 1.0 mg./ml. The identical steps in the development of drug resistance in an experiment in January-February, 1950 (not identical with the experiment given in Table 1 which is based on an experiment performed during November-December, 1949) were 0.00098 mg./ml., 0.0625 mg./ml., 0.25 mg./ml., and the culture finally grew in 1.0 mg./ml. after twenty-six passages.
The experiment with sulfacetamide as given in Table 1 had been carried out two months previously with identical results. After four passages the strain grew in a concentration of 1.0 mg./ml. At that time this was the highest concentration tested.
A surprisingly fast development of drug resistance towards sulfamerazine was also observed in a second series of experiments with very similar results. The minimal active concentration at the different steps such as passages number 0, 3, 6, 12, and 18 were 0.00195 mg./ml., 0.0312 mg./ml., 0.125 mg./ml., 0.5 mg./ml., and more than 1.0 mg./ml. respectively, which constitutes an almost identical replica of the experiments in Table 1 .
The results of drug resistance experiments with the sulfonamide mixtures were, as a rule, very similar to those with the single drugs. Table 2 shows, in condensed form, the development of drug resistance towards the five mixtures which were characterized as mixtures of highly active sulfonamides. The figures given in Table 2 indicate that resistance to the highest concentration tested in these experiments, namely, 1.0 mg./ml., was obtained in twenty-one to twenty-six passages in increasing concentrations of the drug mixtures. Only one of these mixtures produced a resistant strain much faster despite the fact that this agent, mixture D, contained the same constituents (sulfadiazine, sulfathiazole, and sulfamerazine) as mixtures A, B, and C. The experiment was, therefore, repeated with a freshly prepared solution of mixture D once again starting the exposure of the parent strain of E. coli to the drug. The results of this experiment were as follows:
Passage 0: 0.00098 mg./ml. Passage 3: 0.0039 mg./ml. Passage 4: 0.0312 mg./ml. Passage 6: 0.125 mg./ml. Passage 9: 0.5 mg./ml. Passage 10: +1.0 mg./ml. It seemed, therefore, that the tendency to produce drug resistance more rapidly than other compounds was overcome by the presence of sulfathiazole and sulfadiazine in case of mixtures A, B, and C, but became occasionally manifest, e.g. in mixture D.
The experiments with mixture F appeared particularly interesting because this combination contained two sulfonamides of high initial activity, sulfadiazine and sulfamerazine, and one, sulfacetamide, with low initial activity. From the point of view of development of drug resistance the mixture contained two components with a tendency to rapid appearance of drug fastness. It seemed doubtful that the presence of sulfadiazine might counteract the influence of the two other components. Table 3 shows that this was indeed the case. Two experiments carried out with the same strain but two months apart clearly demonstrate that resistance to the final dose of 1.0 mg./ml. was accomplished after twelve passages. The speed with which the strain became drug resistant closely resembled that of sulfamerazine alone, indicating that the presence of sulfadiazine was not sufficient to counteract the influence of two sulfonamides which tend to render a strain resistant rapidly.
Comparative experiments with Gantrisin were included with these tests as well as experiments to show that the sensitivity of the parent strain did not change during the time of these experiments. In fact, the strain of E. coli J has kept its sensitivity to sulfonamides constant for the last four years.
Discussion
Recent experience with combination therapy has shown that combinations of drugs with different sites of attack might produce an interference effect as far as the development of drug resistance is concerned."10 This possibility appeared remote in the case of sulfonamides, particularly when one considers the fact that resistance towards one sulfonamide tends to overlap to the entire group of these agents. The present study on drug resistance of E. coli induced by exposure to sulfonamides or their mixtures seems to confirm this fact, since mixtures showed the same tendency to render E. coli resistant as did their individual components.
Sulfonamides of high activity and one sulfonamide of comparatively low bacteriostatic effect were included in the experiments on the development of drug resistance of E. coli. The drugs also differed as to the speed with which drug resistance was obtained. If we may adopt the term coined by Paul Ehrlich8 and later extended by Schnitzer8 with regard to drug resistance with arsenicals, we could distinguish between compounds of high avidity, e.g. sulfathiazole and sulfadiazine, which produce drug resistance comparatively slowly, and those of low avidity which like sulfacetamide and sulfamerazine induce drug resistance much more rapidly. Drug resistance of a strain of E. coli occurred slowly when the culture was exposed to the first group, namely, sulfonamides of high activity and high avidity. The presence of these drugs in combined preparations was also sufficient to overcome the influence of sulfamerazine which is characterized by high activity and low avidity. One example was found, however, in which a mixture of sulfathiazole, sulfadiazine, and sulfamerazine showed the low degree of avidity characteristic of the last named compound. In one mixture (F) which was a combination of one sulfonamide of high activity and high avidity + one sulfonamide of high activity and low avidity + one of both low activity and low avidity, drug resistance occurred rapidly. Summary 1. In vitro experiments with E. coli carried out for the study of drug resistance towards sulfonamides showed that one can differentiate three types of sulfonamides according to initial bacteriostatic activity and speed of occurrence of maximal-resistance: (a) sulfonamides of high initial activity and high avidity, sulfathiazole and sulfadiazine; (b) sulfonamides of high initial activity and low avidity, sulfamerazine; and (c) sulfonamides of both low initial activity and low avidity, sulfacetamide.
2. In the recently developed triple mixture of sulfonamides the presence of two components of high activity and high avidity overcame, as a rule, the influence of one component of low avidity. The presence of two components of low avidity in a triple mixture consistently resulted in the rapid development of a resistant strain.
3. Included in these studies was work with a new sulfonamide, Gantrisin. It belongs to the group of high initial activity and high avidity.
